Navigation Links
IRIDEX Reports 2013 First Quarter Results
Date:5/2/2013

quarter was approximately double that seen in last year's period, giving us one more indication that we are edging towards a technology-driven tipping point in the market."

Moore continued, "We will look to grow and increase profitability, invest in products that our customers want and that can be delivered to the market rapidly, and be opportunistic in acquiring or partnering with ophthalmic companies that have developed excellent technologies. Peregrine is a great example of such a partnership, as it allows us to market additional consumable products at different price points.  The relationship should lower our supply chain costs and we are already, jointly, working on new product initiatives in the high-margin consumable product category."

The preceding commentary relates to the results of the Company's continuing ophthalmology business. In February 2012, the Company sold its aesthetics laser business and the financial statements reflect the results of its aesthetics laser business as discontinued operations.

Recent Business Highlights

  • The Company entered into a global distribution and supply agreement with Peregrine Surgical, Ltd., a privately held company based in New Britain, Pennsylvania. Under the agreement, IRIDEX will become a worldwide distributor for Peregrine labeled products and Peregrine Surgical will become part of the IRIDEX supply chain for the manufacture of certain IRIDEX products.
  • Following a fourth quarter 2012 FDA 510(k) CE clearance, the Company commenced its full commercial launch of its TxCell Scanning Laser Delivery System. This new product saves significant time in a variety of laser photocoagulation procedures by allowing physicians to deliver the laser in a multi-spot scanning mode, a more efficient method for these procedures than the traditional single spot mode.  Management believes that the clinical and practice benefits of this technology will accelerate the adoption of the proprie
    '/>"/>

  • SOURCE IRIDEX Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
    2. IRIDEX Announces First Quarter 2013 Conference Call and Release Date
    3. IRIDEX Announces Global Distribution and Supply Agreement with Peregrine Surgical, Ltd.
    4. IRIDEX Reports Record 2012 Fourth Quarter Results
    5. IRIDEX Announces Fourth Quarter and Full Year 2012
    6. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
    7. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
    8. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
    9. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
    10. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
    11. IRIDEX Reports 2012 Third Quarter Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... June 24, 2015 ... addition of the "Future Horizons and Growth ... Supplier Shares and Country Forecasts" report to ... Strategies in the European Blood Banking Market 2015 ... to help current suppliers and potential market entrants ...
    (Date:7/1/2015)... Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... disease and neurologic disorders, announced today the results of ... the Company,s lead compound. Results from the study show ... significantly inhibit the activation of inflammatory proteins in the ... compound in a Phase 1 clinical trial under a ...
    (Date:7/1/2015)...  BioPharmX Corporation (NYSE MKT: BPMX) today announced the ... 3,636,364 shares of its common stock at a price ... granted the underwriters a 30-day option to purchase up ... public offering price. In addition, Korea Investment ... agreed to purchase 1,081,081 shares of common stock from ...
    Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3
    ... March 22 Royal Philips Electronics ( PHG, ... medical alert service.  This integrated solution offers an added ... medical alert service with automatic fall detection capabilities. Lifeline ... can automatically call for help if a fall is ...
    ... WALTHAM, Mass. , March 22 Interleukin Genetics, Inc. ... of the NYSE Amex LLC (the "Exchange") has granted the Company an ... Company will remain listed up to June 23, 2010 , subject ... progress towards the Company,s plan to regain compliance. , ...
    Cached Medicine Technology:Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 2Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 3Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 4Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 5Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 6NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 2NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 3
    (Date:7/1/2015)... ... 2015 , ... Amada Senior Care, premier provider of non-medical in-home care and ... – their Mesa, Arizona location . Amada franchise partners Kris Patmos and Kimberly ... rights to the area after years of experience in the sales and healthcare industries. ...
    (Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the ... lead a national chief nursing officer recruitment for Capital Health ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
    (Date:7/1/2015)... ... July 01, 2015 , ... ... firm B. E. Smith, Tri-City Medical Center in Oceanside, Calif., has ... proven record of leading organization-wide compliance adaptation efforts and growing a focus on ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Research published in the journal ... app to test eyesight was just as accurate as those from standard paper-based charts ... Tropical Medicine is responsible for the development of the test, which does not depend ...
    (Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO is pleased ... weighing pans, ML-T balances give operators the room they need to carry out ... estate makes ML-T balances a perfect choice for day-to-day weighing in nearly any ...
    Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Phoenix Area 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2
    ... who suffer from asthma, particularly women, may have an ... of 30 years, researchers studied almost 100,000 patients who ... the patients showed any signs of cancer at their ... year after asthma diagnosis until the last day of ...
    ... is no cure for stiff-person syndrome, a disease marked ... (GAD65), an enzyme involved in the production of a ... which is only mildly successful at controlling symptoms. While ... suspected that it may be an autoimmune disorder. ...
    ... derived a new gel to reduce the hair loss ... side effects of the treatment of cancer. The pharmaceutical ... contains a drug known as GW8510, helped to prevent ... researcher Stephen Davis said the gel completely prevented hair ...
    ... take hormone replacement therapy appear to restore their cognitive ... hormone replacement therapy (HRT) can protect against dementia// is ... failed to demonstrate benefit.A new report, from researchers, ... of over 1,000 women from different countries for a ...
    ... probably get more benefit from investing in gymnasium membership and ... researchers at the Cleavland University // it is better to ... a machine Exercise machines are often advertised in a misleading ... fit to your body, and you may need to learn ...
    ... recent study has found that early puberty and late menopause ... a common symptom of osteoporosis, or brittle bone disease.// Most ... can occur as a result. , ,Researchers in Norway ... as age when her periods start, age when she first ...
    Cached Medicine News:
    Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
    3.5 mm blade. Round handle. Designated most popular model or size....
    2 mm wide x 3 mm long, tapered handle. Angled 45 degrees. Round handle....
    3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
    Medicine Products: